« Opinion From The Region: "Five dynamics to keep your eye on in Lebanon" | Main | Physicists Predict Next 9/11 »

April 20, 2005

Traditional Medicine Derivatives Kill Cancer Cells

Topics: Clinical Pharmacology

(Reuters Health) - Compounds derived from indirubin, a component of a Chinese herbal medicine, can cause human cancer cells to self-destruct, researchers have shown.

A traditional Chinese medicine, Danggui Longhui Wan, is used to treat leukemia. In previous experiments, the active ingredient indirubin has seen to kill cells by blocking an enzyme called CDK and thus interrupting the normal cell cycle.

Now, Dr. Richard Jove, from the Moffitt Cancer Center and Research Institute in Tampa, Florida, and colleagues report in the Proceedings of the National Academy of Sciences on another way that derivatives of the indirubin kill cancer cells.

The researchers discovered that the compounds induce breast and prostate cancer cells to shut down and die by inhibiting a signaling pathway, known as Src-Stat3.

"These findings provide evidence of another mechanism for indirubin's antitumor activity," Jove's group writes.

One of the derivatives, designated E804, was particularly potent in destroying cancer cells and "has potential as an antitumor therapeutic agent in epithelial malignancies," the team concludes.

SOURCE:

Related reading

Posted by Hyscience at April 20, 2005 9:05 AM

Articles Related to Clinical Pharmacology:

• Britain tests first Cannabis related medicine for rheumatoid arthritis - Nov 13, 2005
• Experimental human monoclonal antibody shows striking benefit in patients with advanced melanoma - May 26, 2005
• Cystatin C May Push Creatinine Off Risk Radar - May 19, 2005
• Cancer Treatment Success Stuns Scientists - May 16, 2005
• Antibody, cancer drug combo shows promise against breast tumors - May 16, 2005
• USC researchers determine mechanism of action of motexafin gadolinium (Xcytrin) - May 02, 2005
• Herceptin® Combined With Chemotherapy Improves Disease-Free Survival for Patients With Early-Stage Breast Cancer - Apr 26, 2005
• Selenium will have critical role in prostate cancer treatment - Fox Chase Cancer Center - Apr 21, 2005
• Compound from Chinese medicine shows promise in head and neck cancer, U-M study finds - Apr 19, 2005
• Avastin (Bevacizumab, rhuMAb-VEGF) Plus Chemotherapy Appears to Produce Significant Benefit in First-Line Metastatic Breast Cancer - Apr 18, 2005